Languages
  • Deutsch
  • Español
  • français
  • русский
  • العربية
  • info@iozk.de
    • Deutsch Deutsch German de
    • English English English en
    • Español Español Spanish es
    • Русский Русский Russian ru
    IOZK
    • Home
    • The IOZK
      • Philosophy
      • Team
      • Treatment Center
      • Laboratories
      • Directions and Accommodation
      • Patients Pamphlet
    • The IOZK Immunotherapy
      • IOZK Immunotherapy
      • The Vaccine IO-VAC®
      • The Treatment
      • IOZK Immunotherapy for Different Types of Cancer
      • Therapy Costs
      • FAQ
    • Expert Knowledge
      • IOZK Publications
      • Publications
      • Interesting Facts
    • News
    • Contact
    • Search
    • Menu

    The Team

    Multidisciplinary Expertise for Every Patient

    The IOZK employs around 60 staff members. The medical and scientific experts – together with our dedicated laboratory and nursing team – attend to our patients from all over the world. Every day, they work together to prolong the life of cancer patients with our gentle immunotherapy and to maintain the patient’s quality of life, despite their illness.

    The Team of Experts

    The CEO, Dr. Wilfried Stücker, initiated the IOZK in 1985. In collaboration with various doctors and scientists, he developed the IOZK Immunotherapy and established the treatment centre and laboratories.

    Stefaan Van Gool, MD, PhD, is a specialist in pediatric hemato-oncology with a focus on brain tumors. He is the Head of Translational Oncology at the IOZK. He spent many years at the University Clinic in Leuven and at the Department of Microbiology and Immunology, where he conducted research on the use of vaccines against cancer and published many studies. He leads the team of doctors at the IOZK and is responsible for planning and implementing the IOZK Immunotherapy.

    The scientific side of the IOZK is headed by Prof. Dr. rer. nat. Volker Schirrmacher. He spent over 30 years conducting research at the Deutsche Krebsforschungszentrum (German Cancer Research Centre) in Heidelberg, where he led the Department of Cellular Immunology. He is an internationally recognized pioneer of immunotherapy for cancer, specializing in oncolytic viruses. Together with the scientists and doctors at the IOZK, he works on systematically integrating new scientific findings to further develop the IOZK Immunotherapy.

    Dr. Wilfried Stücker
    mailto:Stuecker@iozk.de

    Dr. Wilfried Stücker

    CEO and Head of the IOZK Team

    Areas of expertise:
    Translational oncology
    Tumor oncology
    Pharmaceutical biology

    IOZK
    Prof. Dr. rer. nat. Volker Schirrmacher
    mailto:V.Schirrmacher@iozk.de

    Prof. Dr. rer. nat. Volker Schirrmacher

    Scientific Director

    Areas of expertise:
    Tumor immunology
    Oncolytic virotherapy

    IOZK
    Stefaan Van Gool MD. PhD.
    mailto:VanGool@iozk.de

    Stefaan Van Gool MD. PhD.

    Medical Director Translational Oncology, Qualified Person (GMP) Responsible Medical Person

    Area of expertise:
    Tumor immunology

    IOZK

    Office of Dr. Wilfried Stücker

    We will gladly answer your questions by e-mail or telephone.
    Please direct your questions to Mr. Angelo Ibba.
    T: +49 (0)221 420 399 127

    Send e-mail

    The Treatment Center

    Medical Doctors

    Montassar Cherif MD.
    mailto:Cherif@iozk.de

    Montassar Cherif MD.

    Medical Doctor, patient care

    Area of expertise:
    Immuno-oncology

    IOZK
    Dr. med. Tobias Sprenger

    Dr. med. Tobias Sprenger

    Specialist in General Practice, Consultant Expert Medical Opinions
    IOZK

    Nursing Team

    Kenan Altuntas

    Kenan Altuntas

    Head of Nursing Team
    IOZK

    Administration

    Funda Kurnaz

    Funda Kurnaz

    Administrative management

    Areas of expertise:
    Medical economist

    IOZK
    Dr. rer. nat. Jennifer Makalowski
    mailto:Makalowski@iozk.de

    Dr. rer. nat. Jennifer Makalowski

    Practice Management, Internal Quality Management

    Areas of expertise:
    Immunology, Molecular biomedicine

    IOZK
    Mahmoud Wahidi
    mailto:Wahidi@iozk.de

    Mahmoud Wahidi

    Operations Manager
    IOZK
    Peter Van de Vliet, PhD PT
    mailto:Vandevliet@iozk.de

    Peter Van de Vliet, PhD PT

    Patient Service Manager / Complaint Manager
    IOZK

    The Laboratory Team

    The IOZK has two laboratories. The Diagnostics Laboratory focuses on research and specialized immunological diagnostics. In the state-of-the-art GMP Production Laboratory our autologous vaccine IO-Vac® is produced. The qualified and highly specialized team works according to the regulations of the German Medicines Act and the European GMP (Good Manufacturing Practice) Guidelines.

    GMP Production Laboratory

    Quality Management

    Diagnostics Laboratory

    HR department / Administration

    Angelo Ibba
    mailto:Ibba@iozk.de

    Angelo Ibba

    Office of Dr. Wilfried Stücker
    IOZK

    Contact us if you have any questions or would like to find out more about the IOZK.

    Send e-mail

    This post is also available in: German Spanish Russian

    • Laboratories
    • Philosophy
    • Team
    • Therapy Costs
    • Treatment Center

    The IOZK

    • Philosophy
    • Team
    • Treatment Center
    • Laboratories
    • Directions and Accommodation

    SPECIALISTS IN IMMUNO-ONCOLOGY

    NEW POSTS

    • Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences
    • Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
    • Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
    • Professor Volker Schirrmacher from the IOZK opened the Symposium on Tumor Immunology at Kiel University with a talk about research on oncolytic viruses in conjunction with a personalized immunotherapy for cancer.
    • International Journal of Oncology: “From chemotherapy to biological therapy”, Prof. Dr. Volker Schirrmacher

    Keywords

    Brain Tumor Checkpoint Inhibitors Chemotherapy Dendritic Cells Dr. Wilfried Stücker Hyperthermia Immunotherapy IO-Vac IOZK-Symposium IOZK Immunotherapy IOZK Team of Experts Liquid Biopsy Newcastle Disease Virus Nobel Prize in Medicine Oncology Oncolytic Viruses Paul Ehrlich Award Personalized Medicine Pontine Glioma Prof. Dr. rer. nat. Volker Schirrmacher Prostate Cancer Publications by Stefaan Van Gool MD. PhD. Stefaan Van Gool MD. PhD. Target Therapy Virotherapy
    IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
    Hohenstaufenring 30–32
    50674 Cologne | Germany

    T: +49 (0)221 – 420 399 25
    F: +49(0)221 - 420 399 26
    E-Mail: info@iozk.de

    The IOZK

    • Philosophy
    • Team
    • Treatment Center
    • Laboratories
    • Directions and Accommodation

    The IOZK Immunotherapy

    • IOZK Immunotherapy
    • The Vaccine IO-VAC®
    • The Treatment
    • IOZK Immunotherapy for Different Types of Cancer
    • Therapy Costs
    • FAQ

    News

    • Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences
    • Award for groundbreaking discovery in immunotherapy goes to Prof. Shimon Sakaguchi
    • Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
    © 2019 IOZK Immun-Onkologisches Zentrum Köln
    • Privacy Statement
    • Cookie Settings
    Scroll to top